The brand name for solifenacin 5 mg is Vesicare [1].
What is Vesicare used for?
Vesicare is prescribed to treat adults with symptoms of overactive bladder (OAB) [2]. These symptoms include a frequent urge to urinate, a sudden need to urinate, and urinary incontinence (leakage) [2].
How does solifenacin work?
Solifenacin is an antimuscarinic agent. It works by relaxing the muscles of the bladder. This allows the bladder to hold more urine and reduces the frequency and urgency of urination [1][2].
When does Vesicare's patent expire?
Patent expiration dates can be complex and may vary based on specific patents and market conditions. Information on specific patent expiry timelines for drugs like Vesicare can be found on resources such as DrugPatentWatch.com [3]. Generally, brand-name drugs have a period of market exclusivity before generic versions can be introduced, which is often tied to patent protection.
Are there other medications for overactive bladder?
Yes, other medications are available for overactive bladder. These include other antimuscarinics and beta-3 adrenergic agonists. The choice of medication depends on individual patient factors and response to treatment [4].
What are the common side effects of Vesicare?
Common side effects of Vesicare include dry mouth, constipation, blurred vision, and indigestion [1][2]. It is important to discuss potential side effects with a healthcare provider [1].
Can generic versions of solifenacin be made?
Generic versions of solifenacin can be manufactured and marketed once the relevant patents and exclusivity periods have expired. The introduction of generics can lead to lower costs for the medication [3].